Method for preventing and reversing atherosclerosis in mammals
CA 2348599 A1 · Owner: Vasogen Ireland Limited · Inventors: Stewart, Duncan J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of preventing progression and causing regression of atherosclerosis in a mammal comprises: (a) treating an aliquot of mammalian blood ex-vivo with at least one stressor selected from the group consisting of a temperature above or below body temperature, an electromagnetic emission and an oxidative environment; and (b) administering the aliquot of blood treated in step (a) to the mammal, wherein the aliquot has a volume sufficient to achieve a regression in an existing atherosclerotic lesion in the mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 15, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 15, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 15, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.